CENCORA INC (ABG.DE) Stock Overview
Europe - FRA:ABG - US03073E1055 - Common Stock
ABG.DE Key Statistics, Chart & Performance
The current stock price of ABG.DE is 286.75 EUR.
ABG.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| AMP.MI | AMPLIFON SPA | 26.97 | 3.54B | ||
| FAGR.BR | FAGRON | 17.63 | 1.53B | ||
| UPR.I | UNIPHAR PLC | 18.18 | 1.04B | ||
| ILM1.DE | MEDIOS AG | 17.24 | 325.51M | ||
| BLC.PA | BASTIDE LE CONFORT MEDICAL | 110 | 178.35M | ||
| VMED.DE | VIROMED MEDICAL AG | N/A | 71.69M |
Related stock screener links
About ABG.DE
Company Profile
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 42,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Company Info
CENCORA INC
1 West First Avenue
Conshohocken PENNSYLVANIA US
Employees: 42000
Phone: 16107277000
CENCORA INC / ABG.DE FAQ
What does ABG do?
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 42,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Can you provide the latest stock price for CENCORA INC?
The current stock price of ABG.DE is 286.75 EUR. The price increased by 0.95% in the last trading session.
Does ABG stock pay dividends?
CENCORA INC (ABG.DE) has a dividend yield of 0.67%. The yearly dividend amount is currently 1.81.
What is the ChartMill technical and fundamental rating of ABG stock?
ABG.DE has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Can you provide the number of employees for CENCORA INC?
CENCORA INC (ABG.DE) currently has 42000 employees.
ABG.DE Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to ABG.DE.
ABG.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to ABG.DE. ABG.DE has an average financial health and profitability rating.
ABG.DE Financial Highlights
Over the last trailing twelve months ABG.DE reported a non-GAAP Earnings per Share(EPS) of 13.36. The EPS increased by 16.64% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.6% | ||
| ROA | 2.57% | ||
| ROE | 95.81% | ||
| Debt/Equity | 4.06 |
ABG.DE Forecast & Estimates
For the next year, analysts expect an EPS growth of 17% and a revenue growth 9.7% for ABG.DE